Inger Njolstad
Overview
Explore the profile of Inger Njolstad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
228
Citations
18593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espnes H, Wilsgaard T, Ball J, Lochen M, Njolstad I, Schnabel R, et al.
JACC Adv
. 2025 Jan;
4(2):101556.
PMID: 39877667
Background: Atrial fibrillation (AF) and heart failure (HF) often coexist and impact morbidity and mortality. There is limited knowledge on the association of AF subtypes with HF according to sex....
2.
Arntsen S, Wilsgaard T, Borch K, Njolstad I, Hansen A
BMJ Open
. 2024 Oct;
14(10):e084109.
PMID: 39419617
Objectives: Investigate associations between body height and cardiovascular disease risk factors at several time points in women and men across educational levels in Norway. Design: Population-based longitudinal study. Setting: The...
3.
Tondel B, Sejrup J, Morelli V, Lochen M, Njolstad I, Mathiesen E, et al.
Res Pract Thromb Haemost
. 2024 Apr;
8(3):102392.
PMID: 38665865
Background: Patients with ischemic stroke have increased risk of venous thromboembolism (VTE). Obesity is prevalent in stroke patients and a well-established risk factor for VTE. Whether obesity further increases the...
4.
Sagelv E, Casolo A, Eggen A, Heitmann K, Johansen K, Lochen M, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2024 Jan;
8(1):62-73.
PMID: 38268988
Objective: To examine the dose-response association between estimated cardiorespiratory fitness (eCRF) and risk of myocardial infarction (MI). Patients And Methods: Adults who attended Tromsø Study surveys 4-6 (Janurary 1,1994-December 20,...
5.
Lundblad M, Broderstad A, Njolstad I
Scand J Public Health
. 2023 Sep;
51(7):973-975.
PMID: 37776175
No abstract available.
6.
Lagou V, Jiang L, Ulrich A, Zudina L, Gonzalez K, Balkhiyarova Z, et al.
Nat Genet
. 2023 Sep;
55(9):1448-1461.
PMID: 37679419
Conventional measurements of fasting and postprandial blood glucose levels investigated in genome-wide association studies (GWAS) cannot capture the effects of DNA variability on 'around the clock' glucoregulatory processes. Here we...
7.
Albrektsen G, Wilsgaard T, Heuch I, Lochen M, Thelle D, Njolstad I, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e030010.
PMID: 37449584
Background The atherosclerotic effect of an adverse lipid profile is assumed to accumulate throughout life, leading to increased risk of myocardial infarction (MI). Still, little is known about age at...
8.
Desai T, Clarke R, Ross S, Grimsgaard S, Njolstad I, Lewington S
Scand J Public Health
. 2023 May;
51(7):1033-1041.
PMID: 37227102
Aims/background: Serial blood pressure surveys in cohort studies can inform public health policies to control blood pressure for prevention of cardiovascular diseases. Methods: Mean levels of systolic blood pressure (SBP)...
9.
Arntsen S, Borch K, Wilsgaard T, Njolstad I, Hansen A
PLoS One
. 2023 Jan;
18(1):e0279965.
PMID: 36696372
Objectives: The objective of our study was to describe time trends in body height according to attained educational level in women and men in Norway. Methods: We used previously collected...
10.
Hagen A, Ariansen I, Hanssen T, Lappegard K, Eggen A, Lochen M, et al.
Eur Heart J Open
. 2022 Oct;
2(5):oeac061.
PMID: 36284643
Aims: To study change over 8 years in cardiovascular risk, achievement of national guideline-based treatment targets of lipids, blood pressure (BP) and smoking in primary prevention of cardiovascular disease (CVD),...